CDXS vs FATE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

CDXS

66.3
AI Score
VS
CDXS Wins

FATE

48.6
AI Score

Investment Advisor Scores

CDXS

66score
Recommendation
HOLD

FATE

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CDXS FATE Winner
Forward P/E 149.2537 0 Tie
PEG Ratio 13.5333 0 Tie
Revenue Growth -2.7% 9.2% FATE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.3/100 48.6/100 CDXS
Profit Margin -39.6% 0.0% FATE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CDXS 1M: -27.8% · 3M: -40.3% FATE 1M: -29.4% · 3M: -46.7%

Current Technical Phase

CDXS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.4%), weak momentum, RSI 30

RSI (14): 30.3 · Price: $0.93

FATE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 25

RSI (14): 25.2 · Price: $1.37

Fundamentals Snapshot

Metric CDXS FATE
Market Cap — —
Forward P/E -3.1 -1.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% -12.0%
Operating Margin -0.8% -15.0%
EPS -0.33 -0.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CDXS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.